![Stephen MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen MacDonald
Comptroller/Controller/Auditor at
PARABILIS MEDICINES, INC.
Profile
Stephen MacDonald is currently Vice President & Corporate Controller at Parabilis Medicines, Inc. Former roles include Senior Finance Director at Tesaro, Inc. and Treasurer, Vice President-Finance & Accounting at Eloxx Pharmaceuticals, Inc. from 2020 to 2021.
Education includes an MBA from Suffolk University and an undergraduate degree from Williams College.
Stephen MacDonald active positions
| Companies | Position | Start |
|---|---|---|
| PARABILIS MEDICINES, INC. | Comptroller/Controller/Auditor | - |
Former positions of Stephen MacDonald
| Companies | Position | End |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Director of Finance/CFO | 26/03/2021 |
| TESARO INC | Director of Finance/CFO | - |
Training of Stephen MacDonald
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Williams College
 Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
- Stock Market
- Insiders
- Stephen MacDonald
